Spinraza 12 mg solution for injection
295SM101
Phase 1 small_molecule active
Quick answer
Spinraza 12 mg solution for injection for Spinal Muscular Atrophy is a Phase 1 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen Idec Ltd
- Indication
- Spinal Muscular Atrophy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active